- Home
- CATX vs ESGL Comparison
CATX vs ESGL Comparison
Compare CATX & ESGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$2.70
Company Overview
Basic Information| Metric | CATX | ESGL |
|---|---|---|
| Founded | 1983 | 1999 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 211.1M | 169.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | CATX | ESGL |
|---|---|---|
| Price | $2.70 | $3.83 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $11.56 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 12.0K |
| Earning Date | 11-10-2025 | 03-03-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $1,075,000.00 | ★ $5,328,277.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.60 | $0.90 |
| 52 Week High | $5.39 | $4.32 |
Technical Indicators
Market Signals| Indicator | CATX | ESGL |
|---|---|---|
| Relative Strength Index (RSI) | 52.19 | 27.65 |
| Support Level | $2.25 | $3.90 |
| Resistance Level | $2.66 | $3.95 |
| Average True Range (ATR) | 0.22 | 0.10 |
| MACD | -0.02 | -0.02 |
| Stochastic Oscillator | 60.56 | 40.91 |
Price Performance
Historical Comparison CATX
ESGL
About CATX Perspective Therapeutics Inc.
Perspective Therapeutics Inc is a radiopharmaceutical development company that is pioneering advanced treatment applications for cancers throughout the body. The Company has a proprietary technology that utilizes the alpha-emitting isotope Lead-212 (212Pb) to deliver powerful radiation specifically to cancer cells via specialized targeting moieties.
About ESGL ESGL Holdings Limited
ESGL Holdings Ltd is a waste management, treatment, and recycling company involved in the collection and recycling of hazardous and non-hazardous industrial waste from customers such as pharmaceutical, semiconductor, petrochemical, and electroplating companies.